Abstract
AbstractFactors correlated with biopsy tissue adequacy and the prevalence of within-biopsy variability were evaluated. Totally, 1149 research biopsies were performed on 686 patients from which 5090 cores were assessed. Biopsy cores were reviewed for malignant percentage (estimated percentage of cells in the core that were malignant) and malignant area (estimated area occupied by malignant cells). Linear mixed models and generalized linear mixed models were used for the analysis. A total of 641 (55.8%) biopsies contained a core with <10% malignant percentage (inadequate core). The chance of an inadequate core was not influenced by core order, though the malignant area decreased with each consecutive core (p < 0.001). Younger age, bone biopsy location, appendiceal tumor pathology, and responding/stable disease prior to biopsy increased the odds of a biopsy containing zero adequate cores. Within-biopsy variability in core adequacy is prevalent and suggests the need for histological tumor quality assessment of each core in order to optimize translational analyses.
Funder
The University of Texas MD Anderson Cancer Center Moon Shots Program™
Publisher
Springer Science and Business Media LLC
Subject
Computer Science Applications,History,Education
Reference39 articles.
1. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer (Version 8.2020). https://www.nccn.org/professionals/physician_gls/pdf/nscl_blocks.pdf (2020).
2. National Comprehensive Cancer Network. Breast Cancer (Version 6.2020). https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf (2020).
3. National Comprehensive Cancer Network. Colon Cancer (Version 4.2020). https://www.nccn.org/professionals/physician_gls/pdf/colon_blocks.pdf (2020).
4. Yap, T. A., Banerji, U., de Bono, J. S. & Workman, P. Biopsy-derived biomarkers in phase I trials: building confidence in drug development. J. Clin. Oncol. 34, 2431–2432 (2016).
5. Banerji, U., de Bono, J., Judson, I., Kaye, S. & Workman, P. Biomarkers in early clinical trials: the committed and the skeptics. Clin. Cancer Res. 14, 2512 (2008). author reply 2513–2514.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献